×ÛÊö£ºÎ¬ÉúËØºÍÖ²Îï¶à·Ó¶ÔË¥Àϱí¹ÛÒÅ´«µ÷¿ØµÄЭͬЧӦ

¡¶Egyptian Journal of Medical Human Genetics¡·£ºSynergistic effects of vitamins and plant polyphenols on epigenetic regulation of aging

¡¾×ÖÌ壺 ´ó ÖРС ¡¿ ʱ¼ä£º2026Äê07ÔÂ30ÈÕ À´Ô´£ºEgyptian Journal of Medical Human Genetics 1.3

±à¼­ÍƼö£º

¡¡¡¡±³¾°£ºË¥ÀÏÊÇÒ»¸ö¸´ÔÓµÄÉúÎïѧ¹ý³Ì£¬ÊÜÒÅ´«¡¢±í¹ÛÒÅ´«ºÍ»·¾³ÒòËØÓ°Ïì¡£ÓªÑøÀÏÄê¿ÆÑ§ºÍ±í¹Û»ùÒò×éѧµÄ×îнøÕ¹±íÃ÷£¬Î¬ÉúËØºÍÖ²Îï¶à·ÓÔÚµ÷½Úµ÷¿ØË¥ÀϺÍÄêÁäÏà¹Ø¼²²¡µÄ±í¹ÛÒÅ´«»úÖÆÖз¢»Ó¹Ø¼ü×÷Óá£Ä¿µÄ£º±¾×ÛÊöÖ¼ÔÚ²ûÃ÷άÉúËØºÍÖ²Îï¶à·Ó×éºÏ¶ÔË¥Àϱí¹ÛÒÅ´«µ÷¿ØµÄЭͬЧӦ£¬Ç¿µ÷·Ö×Ó

¡¡¡¡
±³¾°£ºË¥ÀÏÊÇÒ»¸ö¸´ÔÓµÄÉúÎïѧ¹ý³Ì£¬ÊÜÒÅ´«¡¢±í¹ÛÒÅ´«ºÍ»·¾³ÒòËØÓ°Ïì¡£ÓªÑøÀÏÄê¿ÆÑ§ºÍ±í¹Û»ùÒò×éѧµÄ×îнøÕ¹±íÃ÷£¬Î¬ÉúËØºÍÖ²Îï¶à·ÓÔÚµ÷½Úµ÷¿ØË¥ÀϺÍÄêÁäÏà¹Ø¼²²¡µÄ±í¹ÛÒÅ´«»úÖÆÖз¢»Ó¹Ø¼ü×÷Óá£Ä¿µÄ£º±¾×ÛÊöÖ¼ÔÚ²ûÃ÷άÉúËØºÍÖ²Îï¶à·Ó×éºÏ¶ÔË¥Àϱí¹ÛÒÅ´«µ÷¿ØµÄЭͬЧӦ£¬Ç¿µ÷·Ö×Ó»úÖÆ¡¢ÁÙ´²Ö¤¾ÝÒÔ¼°Õë¶Ô¸öÌå±í¹ÛÒÅ´«Í¼Æ×¶¨ÖƵľ«×¼ÓªÑø²ßÂÔµÄDZÁ¦¡£Ö÷Ì壺άÉúËØ×÷ΪӰÏìDNA¼×»ù»¯£¨DNA methylation£©ºÍ×éµ°°×ÐÞÊΣ¨histone modifications£©µÄø´Ù·´Ó¦ÖеıØÐ踨Òò×Ó£¬¶ø¶à·Óµ÷½Úת¼Òò×ÓºÍϸ°ûÓ¦¼¤·´Ó¦¡£ËüÃǵÄÁªºÏ¸øÒ©ÔöÇ¿ÁËÉúÎïÀûÓöȺÍÎȶ¨ÐÔ£¬´Ó¶øÄܹ»ÓÅÔ½µØµ÷¿Ø¹Ø¼üË¥ÀÏͨ·£¬ÈçsirtuinÐźÅͨ·£¨sirtuin signaling£©¡¢×ÔÊÉ£¨autophagy£©ºÍÑõ»¯Ó¦¼¤·´Ó¦£¨oxidative stress responses£©¡£À´×Ô¶à×éѧÑо¿£¨multi-omics studies£©ºÍÁÙ´²ÊÔÑéµÄÖ¤¾ÝÖ§³ÖÌØ¶¨µÄЭͬ¶Ô£¬°üÀ¨Î¬ÉúËØCÓë»ÆÍªÀ໯ºÏÎάÉúËØDÓë°×޼«´¼£¨resveratrol£©¡¢B×åάÉúËØÓë¶à·ÓËᣨpolyphenolic acids£©ÒÔ¼°Î¬ÉúËØEÓë¶ù²èËØ£¨catechins£©¡£ÕâЩÏ໥×÷ÓôٽøÓÐÒæµÄ±í¹ÛÒÅ´«ÖØËÜ£¨epigenetic remodeling£©£¬¼õÉÙÑ×֢˥ÀÏ£¨inflammaging£©£¬²¢¸ÄÉÆ½¡¿µË¥ÀϵÄÉúÎï±êÖ¾Îï¡£»úÆ÷ѧϰºÍµÝËͼ¼ÊõµÄ½ø²½½øÒ»²½´Ù½øÁ˸öÐÔ»¯¸ÉÔ¤¡£½áÂÛ£ºÎ¬ÉúËØ-¶à·ÓЭͬ×÷Óôú±íÁ˾«×¼ÓªÑø»ùÒò×éѧ£¨precision nutrigeromics£©ÖÐÒ»¸öÓÐǰ¾°µÄ·¶Ê½£¬ÎªÐÂÐÍ¿¹Ë¥ÀϲßÂÔÌṩÁË»úÖÆ»ù´¡¡£Î´À´µÄÑо¿Ó¦²àÖØÓÚ±ê×¼»¯µÄÆÀ¹À·½·¨¡¢³¤ÆÚÁÙ´²ÑéÖ¤ÒÔ¼°ÓÅ»¯µÝËÍϵͳ£¬ÒÔ³ä·Ö·¢»ÓÆäÔÚÑÓ³¤½¡¿µÊÙÃü·½ÃæµÄÖÎÁÆÇ±Á¦¡£
**The epigenetic revolution in aging research**£º±í¹ÛÒÅ´«ÐÞÊÎÊÇË¥ÀϺͳ¤ÊٵĹؼü½éÖÊ£¬»ùÓÚDNA¼×»ù»¯Ä£Ê½£¨DNA methylation patterns£©µÄ±í¹ÛÒÅ´«Ê±ÖÓ£¨epigenetic aging clocks£©³ÉΪ±Èʵ¼ÊÄêÁä¸ü׼ȷµÄÉúÎïÄêÁäÔ¤²â¹¤¾ß¡£HorvathʱÖӺͱí¹ÛÒÅ´«ÄêÁä¼ÓËÙÖ¸±êµÈʱÖÓ¶ÔάÉúËØ-¶à·ÓÁªºÏ¸ÉÔ¤ÓÐÏìÓ¦£¬¿ÉÁ¿»¯ÆÀ¹À¸ÉԤЧ¹û¡£·Ç±àÂëRNA£¨non-coding RNAs£©£¬°üÀ¨Î¢Ð¡RNA£¨microRNAs£©¡¢³¤Á´·Ç±àÂëRNA£¨long non-coding RNAs£©ºÍ»·×´RNA£¨circular RNAs£©£¬×÷Ϊ¹Ø¼ü±í¹ÛÒÅ´«µ÷¿ØÒò×Ó£¬Ó°Ïìϸ°ûË¥ÀϺʹúлÎÈ̬¡£

**Nutritional geroscience: from caloric restriction to molecular nutrition**£ºÓªÑøÀÏÄê¿ÆÑ§£¨nutritional geroscience£©´ÓÈÈÁ¿ÏÞÖÆµÈ¹ã·ºÒûʳ¸ÉÔ¤·¢Õ¹Îª¾«È··Ö×ÓÓªÑø£¬°ÐÏòÌØ¶¨Ë¥ÀÏͨ·¡£ÓªÑø»ùÒò×éѧ£¨nutrigeromics£©Ñо¿ÓªÑøËØÓëË¥ÀÏ»ùÒò×éµÄÏ໥×÷Ó᣼¤ËØÐ§Ó¦£¨hormesis£©ÊÇÓªÑøËØ·¢»Ó¿¹Ë¥ÀÏ×÷ÓõĻù±¾»úÖÆ£¬Éæ¼°¼¤»îÓ¦¼¤·´Ó¦Í¨Â·ÒÔÔöǿϸ°ûÈÍÐÔ¡£

**Synergy definition and operationalization framework**£ºÐ­Í¬×÷ÓÃÒÀ¾ÝÒ©ÀíѧԭÔò¶¨Ò壬°üÀ¨»úÖÆÐÔЭͬ£¨×éºÏÖ¸ÊýCI<1.0£©¡¢Ò©´ú¶¯Á¦Ñ§Ð­Í¬£¨ÉúÎïÀûÓöÈÌá¸ß20-50%£©¡¢Ïà¼ÓЧӦ£¨CI=1.0£©ºÍ¼ÙÉèÐÔ/ÌáʾÐÔ¹ØÁª¡£±¾×ÛÊöÔÚÎı¾ºÍ±í¸ñÖÐÃ÷È·±ê×¢Ö¤¾Ý¼¶±ð£¬ÒÔÇø·Ö»úеÐÔ·¢ÏÖÓëÐÂÐ˼ÙÉ裬ÃÖ²¹ÏÈÇ°ÓªÑø×ÛÊöÖÐȱ·¦±ê×¼»¯Ð­Í¬ÆÀ¹ÀµÄ²»×ã¡£

**Rationale for vitamin-polyphenol synergies**£ºÎ¬ÉúËØ×÷Ϊø´Ù·´Ó¦ºÍ±í¹ÛÒÅ´«ÐÞÊεĸ¨Òò×Ó£¬¶à·Ó×÷ΪÐźŷÖ×Óµ÷½Úת¼Òò×ÓºÍϸ°ûÓ¦¼¤·´Ó¦£¬Á½Õß»¥²¹ÐÔÌáʾÁªºÏ×÷ÓÿÉÄܲúÉú³¬¼ÓºÍЧӦ¡£Î¬ÉúËØ¿ÉÔöÇ¿¶à·ÓµÄÎüÊÕºÍÑÓ³¤°ëË¥ÆÚ£¬À¶Çø£¨Blue Zones£©ºÍµØÖк£ÈËȺµÈ³¤ÊÙÈÈµãµØÇø¹Û²ìµ½¸ßάÉúËØºÍ¶à·ÓÉãÈ룬֧³ÖÁªºÏÏû·Ñ¡£

**Review scope and evidence grading framework**£º±¾×ÛÊöÄÉÈë»úÖÆÐÔÑо¿¡¢ÁÙ´²ÊÔÑéºÍÈËȺÑо¿£¬Ö¤¾Ý·ÖΪÁÙ´²Ç°£¨P£©¡¢»ìºÏ£¨M£©ºÍËæ»ú¶ÔÕÕÊÔÑé/ÜöÝÍ·ÖÎö£¨R£©Èý¼¶£¬ÔÚ±í1ºÍ2Öбê×¢£¬±ÜÃâ¶Ô³õ²½·¢ÏÖ¹ý¶È½â¶Á¡£

**Hallmarks of aging: an epigenetic perspective**£º´Ó±í¹ÛÒÅ´«½Ç¶È£¬»ùÒò×é²»Îȶ¨ÐÔÉæ¼°DNAËðÉË»ýÀÛºÍÐÞ¸´»úÖÆ¸Ä±ä£¬ÊÜÓªÑø¸ÉÔ¤Ó°ÏìµÄ±í¹ÛÒÅ´«ÐÞÊε÷¿Ø¡£¶ËÁ£ÉúÎïѧÓë±í¹ÛÒÅ´«µ÷¿ØÏàÁ¬£¬¶ËÁ£È¾É«ÖÊ·¢ÉúÄêÁäÏà¹Ø±ä»¯Ó°Ïì¶ËÁ£Ã¸»îÐÔ¡£Ï¸°ûË¥ÀϰéËæË¥ÀÏÏà¹Ø·ÖÃÚ±íÐÍ£¨SASP£¬senescence-associated secretory phenotype£©£¬Éæ¼°¿É±»Ìض¨ÓªÑøËص÷½ÚµÄ±í¹ÛÒÅ´«Öرà³Ì¡£ÏßÁ£Ì幦ÄÜÕϰ­Óë±í¹ÛÒÅ´«´®ÈÅÌṩͬʱ°ÐÏòºËºÍÏßÁ£ÌåË¥ÀϹý³ÌµÄ»ú»á¡£

**Key epigenetic mechanisms in aging**£ºDNA¼×»ù»¯£¨DNA methylation£©±ä»¯°üÀ¨È«¾ÖµÍ¼×»ù»¯ºÍÌØ¶¨»ùÒòÆô¶¯×Ó¾Ö²¿¸ß¼×»ù»¯£¬CpGµº¼×»ù»¯±íÐÍ£¨CIMP£¬CpG island methylator phenotype£©Ó°Ïì¶àÌõͨ·¡£DNA¼×»ù×ªÒÆÃ¸£¨DNMTs£¬DNA methyltransferases£©ºÍTET£¨ten-eleven translocation£©Ã¸Æ½ºâά³Ö¼×»ù»¯ÎÈ̬¡£×éµ°°×ÐÞÊΣ¨histone modifications£©ÈçH3K4me3¡¢H3K27me3ºÍË«¼ÛȾɫÖʽṹÓòËæË¥Àϸı䣬×éµ°°×È¥ÒÒõ£»¯Ã¸£¨HDACs£¬histone deacetylases£©ºÍÒÒõ£×ªÒÆÃ¸£¨HATs£¬histone acetyltransferases£©µ÷½ÚȾɫÖʿɼ°ÐÔ¡£Î¢Ð¡RNA£¨microRNAs£©µ÷¿ØÏ¸°ûË¥ÀÏÏà¹Ø»ùÒò±í´ï£¬³¤Á´·Ç±àÂëRNAЭµ÷ȾɫÖÊÖØËÜ£¬»·×´RNA×÷Ϊ¾ºÕùÐÔÄÚÔ´RNAµ÷½Ú΢СRNA»îÐÔ¡£

**Master regulators of aging and longevity**£ºsirtuin¼Ò×壨SIRT1-7£©ÒÔNAD+Ϊ¸¨Òò×Ó£¬Á¬½Ó´úлÓëË¥ÀÏ£¬µ÷¿Ø×éµ°°×ºÍ·Ç×éµ°°×ÒÒõ£»¯£¬Ó°ÏìDNAÐÞ¸´ºÍ¶ËÁ£Î¬³Ö¡£FOXOת¼Òò×ÓÊÇÓ¦¼¤µÖ¿¹ºÍ³¤ÊÙµÄÖ÷µ÷¿ØÒò×Ó£¬ÕûºÏÒȵºËØ/IGF-1ÐźźÍAMPK£¨AMP-activated protein kinase£©¼¤»î£¬¿ØÖÆ¿¹Ñõ»¯Ã¸¡¢DNAÐÞ¸´µ°°×ºÍ×ÔÊɵ÷½ÚÒò×Ó±í´ï¡£mTOR£¨mechanistic target of rapamycin£©ÐźźÍ×ÔÊɵ÷¿ØÊÇË¥ÀÏ¿ØÖÆÖÐÊ࣬mTORC1ºÍmTORC2ƽºâ¾ö¶¨Ë¥ÀϹ켣¡£

**Vitamin D and the vitamin D receptor (VDR)**£ºÎ¬ÉúËØDͨ¹ýºËÊÜÌåVDR£¨vitamin D receptor£©×÷ΪÅäÌ弤»îת¼Òò×Ó£¬½áºÏάÉúËØD·´Ó¦Ôª¼þ£¨VDREs£¬vitamin D response elements£©£¬ÕÐļ¹²¼¤»î¸´ºÏÎï¸Ä±äȾɫÖʽṹ¡£ÁÙ´²Ö¤¾Ý£ºËæ»ú¶ÔÕÕÊÔÑéºÍÜöÝÍ·ÖÎöÏÔʾ£¬Î¬ÉúËØD3²¹³ä£¨1000-4000 IU/Ì죩12-24¸öÔ¿ÉÏÔÖø±£´æ¹ÇÃܶȣ¨Ð§Ó¦Á¿Cohen's d=0.3-0.6£©£¬×î¼ÑάÉúËØD״̬£¨>30 ng/mL£©ÓëÀÏÄêÈ˸ÐȾÂʽµµÍºÍ×ÜËÀÍöÂʽµµÍÏà¹Ø¡£

**Vitamin A/retinoids**£ºÊÓ»ÆËáÊÜÌ壨RARs£¬retinoic acid receptors£©Í¨¹ýÓ°Ïìϸ°û·Ö»¯¡¢ÃâÒßÎÈ̬ºÍ±í¹ÛÒÅ´«ÖØËܵ÷½ÚË¥ÀÏͨ·¡£Î¬ÉúËØAÔÚÆ¤·ôË¥ÀϺ͹Ᵽ»¤ÖÐÉæ¼°Ö±½Ó¿¹Ñõ»¯ºÍͨ¹ýºËÊÜÌåÐźŵ÷½Ú»ùÖʽðÊôµ°°×ø±í´ï¡£

**Vitamin E and tocopherols/tocotrienols**£º³ý¿¹Ñõ»¯Í⣬άÉúËØE·¢»Ó»ùÒòµ÷¿Ø¹¦ÄÜ£¬Ó°ÏìHDAC»îÐÔºÍ×éµ°°×ÒÒõ£»¯Ä£Ê½¡£¦Á-¡¢¦Â-¡¢¦Ã-¡¢¦Ä-ÉúÓý·ÓºÍÉúÓýÈýÏ©·Ó¶ÔSIRT1¼¤»îºÍNAD+ÉúÎïÀûÓöÈÓвîÒìЧӦ£¬¦Ã-ÉúÓý·ÓÔÚÁÙ´²Ç°Ñо¿ÖÐÏÔʾ½ÏÇ¿±í¹ÛÒÅ´«Ð§Ó¦¡£

**Vitamin K**£º»ùÖÊGlaµ°°×£¨matrix Gla protein£©ÊÇάÉúËØKÒÀÀµÐÔµ°°×£¬Í¨¹ýÔ¤·À¶¯Âö¸Æ»¯ºÍµ÷½ÚÑ×Ö¢·´Ó¦ÔÚѪ¹ÜË¥ÀÏÖÐÆð¹Ø¼ü×÷Óá£Î¬ÉúËØK»¹Í¨¹ý¦Ã-ôÈ»ù¹È°±ËáºÏ³ÉÓ°Ïì×éµ°°×ÐÞÊÎģʽ¡£

**B-complex vitamins and one-carbon metabolism**£ºB×åάÉúËØ£¨Ò¶ËáB9¡¢Î¬ÉúËØB12¡¢Î¬ÉúËØB6¡¢ºË»ÆËØ£©ÔÚһ̼´úлÖÐÆðºËÐÄ×÷Óã¬ÎªDNA¼×»ù»¯Î¬³ÖÌṩ¼×»ù¹©ÌåS-ÏÙÜÕ¼×Áò°±ËᣨSAM£¬S-adenosylmethionine£©¡£Î¬ÉúËØB6²ÎÓëתÁòͨ·µ÷½ÚÑõ»¯Ó¦¼¤£¬¸ßͬÐͰëë×°±Ëáˮƽ£¨B×åάÉúËØ×´Ì¬²»×ã±êÖ¾ÎÓë¼ÓËÙ±í¹ÛÒÅ´«ÄêÁäºÍÈÏ֪˥ÍËÏà¹Ø¡£

**Vitamin C (ascorbic acid)**£ºÎ¬ÉúËØCÔÚTETø¹¦ÄܺÍDNAÈ¥¼×»ù»¯ÖÐÆð¹Ø¼ü×÷Óã¬Ö±½ÓÁ¬½Ó¿¹»µÑªËá¿ÉÓÃÐÔÓë±í¹ÛÒÅ´«ÄêÁäÄæ×ª¡£×îз¢ÏÖÇ¿µ÷άÉúËØCͨ¹ýTET½éµ¼µÄÖ÷¶¯È¥¼×»ù»¯ÔÚ¸Éϸ°ûÖØ±à³ÌºÍ¶àÄÜÐÔά³ÖÖеÄ×÷Óá£

**Vitamin-specific aging biomarkers**£ºÎ¢Á¿ÓªÑøËØ×´Ì¬Óë±í¹ÛÒÅ´«ÄêÁä¼ÓËÙÏà¹Ø£¬Ìض¨Î¬ÉúËØÈ±·¦ÓëÉý¸ßµÄ±í¹ÛÒÅ´«Ê±ÖÓÆÀ·ÖºÍ½µµÍµÄ´úлÁé»îÐÔÏà¹Ø¡£

**Classification and bioavailability**£º»ÆÍªÀ໯ºÏÎflavonoids£©ÊÇ×î´ó¶à·ÓÀ࣬°üÀ¨éÎÆ¤ËØ¡¢¶ù²èËØ¡¢»¨ÇàËØºÍÒì»ÆÍª£¬¸÷ÓжÀÌØ±í¹ÛÒÅ´«°ÐÏòÌØÕ÷¡£Ä¾ÖÊËØ£¨lignans£©È糦¶þ´¼ºÍ³¦ÄÚõ¥Óɳ¦µÀ¾úȺ´úл£¬Óë±í¹ÛÒÅ´«ÖØËܺ͸ÄÉÆ´úл˥ÀÏÏà¹Ø¡£IÏàºÍIIÏàÉúÎïת»¯ÏÔÖøÓ°Ïì¶à·ÓÉúÎïÀûÓöȣ¬´úлø£¨ÈçCOMT¡¢MAO¡¢CYP1A2£©ÒÅ´«¶à̬ÐÔÓ°Ïì¶à·ÓÏò»îÐÔ´úлÎïµÄת»¯¼°Æä±í¹ÛÒÅ´«Ð§ÄÜ¡£

**Molecular targets and mechanisms**£º¶à·ÓÈçEGCG£¨epigallocatechin gallate£©¡¢½ðȸÒì»ÆÍª£¨genistein£©ºÍ½ª»ÆËØ£¨curcumin£©Ö±½ÓÒÖÖÆDNMT£¬Äæ×ªÓëË¥ÀÏÏà¹ØµÄÒì³£¸ß¼×»ù»¯£¨Ö¤¾ÝµÈ¼¶£ºÁÙ´²Ç°£©¡£¶à·Ó¼¤»îNRF2£¨nuclear factor erythroid 2-related factor 2£©´¥·¢¼¤ËØÓ¦¼¤·´Ó¦£¬ÔöÇ¿¿¹Ñõ»¯»ùÒò±í´ï£»°×޼«´¼£¨resveratrol£©µÈ¼¤»îSIRT1£¨sirtuin 1£©£¬Ôö¼ÓNAD+ÒÀÀµÐÔÈ¥ÒÒõ£»¯¡£

**Polyphenol-rich dietary patterns**£ºµØÖк£Òûʳ¸»º¬éÏé­ÓÍ¡¢ºì¾ÆºÍË®¹ûÖеĶà·Ó£¬ÔÚǰհÐÔ¶ÓÁÐÑо¿ºÍËæ»ú¶ÔÕÕÊÔÑéÖÐÓëÑÓ³¤½¡¿µÊÙÃüºÍ½µµÍÄêÁäÏà¹Ø¼²²¡·¢²¡Âʹ㷺Ïà¹Ø¡£

**Theoretical framework for synergy**£ºÒ©´ú¶¯Á¦Ñ§Ð­Í¬É漰άÉúËØºÍ¶à·ÓÁªºÏʱÎüÊÕ¡¢·Ö²¼ºÍ´úлÔöÇ¿£¬¿Éͨ¹ý±È½ÏÉúÎïÀûÓöÈÑо¿ºÍÒ©´ú¶¯Á¦Ñ§½¨Ä£²âÁ¿¡£ÀýÈ磬άÉúËØC¹²¸øÒ©Í¨¹ýÔöÇ¿³¦µÀÎüÊÕ»úÖÆÊ¹»ÆÍªÀàÎüÊÕÌá¸ß30-50%¡£ÏµÍ³ÉúÎïѧ½¨Ä£ºÍÍøÂçÒ©Àíѧ·½·¨·ÖÎö¸´ÔÓЭͬЧӦ¡£

**Documented vitamin-polyphenol synergies**£ºÎ¬ÉúËØC+»ÆÍªÀࣺ»úÖÆÉæ¼°»ÆÍªÔÙÉúºÍÉúÎïÀûÓöÈÔöÇ¿¡£Ëæ»ú¶ÔÕÕÊÔÑ飨n=120£¬12ÖÜ£©ÏÔʾ£¬Î¬ÉúËØC£¨500 mg/Ì죩¼Ó»ìºÏ»ÆÍª£¨500 mg/Ì죩¸ÄÉÆÄÚÆ¤¹¦ÄÜ£¨ÑªÁ÷½éµ¼À©ÕÅ£©35%£¬Ô¶¸ßÓÚµ¥¶ÀʹÓã¨12%ºÍ8%£©£¬Ö§³Ö»úÖÆÐÔЭͬ£¨CI<1.0£©¡£Î¬ÉúËØD+°×޼«´¼£ºVDRºÍSIRT1ͨ·»ã¾ÛÓÚp53ÒÒõ£»¯ºÍϸ°ûË¥ÀÏÔ¤·À¡£»ìºÏÖ¤¾ÝÏÔʾ£¬ÁªºÏ²¹³äάÉúËØD£¨2000 IU/Ì죩ºÍ°×޼«´¼£¨150 mg/Ì죩Óë¸ÄÉÆ¹ÇÃܶÈÏà¹Ø£¬µ«È±·¦È·ÔäRCT¡£B×åάÉúËØ+¶à·ÓË᣺һ̼´úлÓë·Ó¼×»ù»¯Í¨Â·Ï໥×÷Ó㬿ÉÄÜÔöÇ¿½µµÍͬÐͰëë×°±ËáºÍ¸ÄÉÆ±í¹ÛÒÅ´«¼×»ù»¯Æ½ºâµÄЧ¹û£¬µ«ÏÖÓÐÖ¤¾ÝÖ÷ҪΪ¹Û²ìÐÔ£¬È±·¦ÕýʽЭͬ²âÊÔ¡£Î¬ÉúËØE+¶ù²èËØ£ºÖ¬ÖʹýÑõ»¯Ô¤·ÀºÍĤÎȶ¨ÐÔÒò»¥²¹»úÖÆÔöÇ¿£¬ÁÙ´²Ç°ÏÔʾCI=0.72£¬µ«ÈËÌåÁÙ´²Ö¤¾ÝÓÐÏÞ¡£

**Emerging synergistic combinations**£ºÎ¬ÉúËØK2Óë¶à·Ó¿¹Ñõ»¯¼ÁÔÚ¹ÇË¥ÀÏÔ¤·ÀÖÐÏÔʾ³öÔçÆÚÁÙ´²Ç°Ç±Á¦£¬µ«ÉÐδ½øÐÐÕýʽЭͬ²âÊÔ£¬ÊôÓÚ¼ÙÉèÐÔ¹ØÁª¡£

**Omics technologies**£ºÈ«»ùÒò×éÑÇÁòËáÑβâÐò¿Éʶ±ðάÉúËØ-¶à·Ó¸ÉÔ¤ºóµÄ°ÐÏò±í¹ÛÒÅ´«±ä»¯¡£µÚÒ»´ú±í¹ÛÒÅ´«Ê±ÖÓ£¨Horvath DNAmʱÖÓ¡¢HannumʱÖÓ£©ÔÚСÐÍÑо¿ÖÐÏÔʾ¶Ô¶àģʽÒûʳ¿¹Ñõ»¯¸ÉÔ¤ÓÐÊʶÈÏìÓ¦£¨±í¹ÛÒÅ´«ÄêÁä¼ÓËÙ¼õÉÙ1-3Ä꣩¡£µÚ¶þ´úʱÖÓ£¨PhenoAge¡¢GrimAge£©ÕûºÏ±íÐÍË¥ÀϱêÖ¾ÎÔÚµØÖк£ÒûʳÊÔÑéÖй۲쵽GrimAge¼õËÙ£¬µ«Ö±½ÓÖ¤¾ÝÓÐÏÞ£¬Ðè¸ü´óÑù±¾£¨n>200£©ºÍ1-2ÄêËæ·ÃµÄRCT¡£

**Multi
Ïà¹ØÐÂÎÅ
ÉúÎïͨ΢ÐŹ«ÖÚºÅ
΢ÐÅ
ÐÂÀË΢²©
  • ËÑË÷
  • ¹ú¼Ê
  • ¹úÄÚ
  • ÈËÎï
  • ²úÒµ
  • Èȵã
  • ¿ÆÆÕ

ÈȵãÅÅÐÐ

    ½ñÈÕ¶¯Ì¬ | È˲ÅÊг¡ | м¼ÊõרÀ¸ | Öйú¿ÆÑ§ÈË | ÔÆÕ¹Ì¨ | BioHot | ÔÆ½²ÌÃÖ±²¥ | »áÕ¹ÖÐÐÄ | ÌØ¼ÛרÀ¸ | ¼¼Êõ¿ìѶ | Ãâ·ÑÊÔÓÃ

    °æÈ¨ËùÓÐ ÉúÎïͨ

    Copyright© eBiotrade.com, All Rights Reserved

    ÁªÏµÐÅÏ䣺

    ÔÁICP±¸09063491ºÅ